Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hou, Zhaohua ^a   Zhang, Jian ^a   Han, Qiuju ^a   Su, Chenhe ^a   Qu, Jing ^a   Xu, Dongqing ^a   Zhang, Cai ^a   Tian, Zhigang ^b,c  

^a SHANDONG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DDX58 PROTEIN, HUMAN; IFIT3 PROTEIN, HUMAN; MICRORNA; MIRN146 MICRORNA, HUMAN; RETINOIC ACID INDUCIBLE PROTEIN I; SIGNAL PEPTIDE;

ANIMAL; CELL LINE; DISEASE MODEL; HEPATITIS B; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; LIVER CELL; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

ANIMALS; CELL LINE; DEAD BOX PROTEIN 58; DISEASE MODELS, ANIMAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84971350180     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26150     Document Type: Article

References (41)

1. Ratnam, D. & Visvanathan, K. New concepts in the immunopathogenesis of chronic hepatitis B: the importance of the innate immune response. Hepatol Int 2, 12-18 (2008).
2. Han, Q., Zhang, C., Zhang, J. & Tian, Z. The role of innate immunity in HBV infection. Semin Immunopathol 35, 23-38 (2013).
3. Guo, H. et al. Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells. J Virol 83, 847-858 (2009).
4. Isogawa, M., Robek, M. D., Furuichi, Y. & Chisari, F. V. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 79, 7269-7272 (2005).
5. Chisari, F. V. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol 206, 149-173 (1996).
6. Han, Q., Zhang, C., Zhang, J. & Tian, Z. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBxsiRNAs in a retinoic acid inducible gene I-dependent manner. Hepatology 54, 1179-1189 (2011).
7. Yu, S. et al. Hepatitis B virus polymerase inhibits RIG-I-and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J Gen Virol 91, 2080-2090 (2010).
8. Kumar, M. et al. Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon. J Virol 85, 987-995 (2011).
9. Wang, X. et al. Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-beta induction by disrupting the VISA-associated complex. Cell Mol Immunol 7, 341-348 (2010).
10. Jiang, J. & Tang, H. Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein. Protein Cell 1, 1106-1117 (2010).
11. Mizuguchi, Y., Takizawa, T. & Uchida, E. Host cellular microRNA involvement in the control of hepatitis B virus gene expression and replication. World J Hepatol 7, 696-702 (2015).
12. Zhang, X., Hou, J. & Lu, M. Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs. Front Genet 4, 202 (2013).
13. Kroesen, B. J. et al. Immuno-miRs: critical regulators of T-cell development, function and ageing. Immunology 144, 1-10 (2015).
14. Hou, J. et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 183, 2150-2158 (2009).
15. Liu, Y. et al. Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line. Chin Med J (Engl) 122, 10-14 (2009).
16. Zhang, Z. Z. et al. Hepatitis B virus and hepatocellular carcinoma at the miRNA level. World J Gastroenterol 17, 3353-3358 (2011).
17. Guo, H. et al. MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology 54, 808-819 (2011).
18. Wang, S. et al. MicroRNA-146a feedback suppresses T cell immune function by targeting Stat1 in patients with chronic hepatitis B. J Immunol 191, 293-301 (2013).
19. Hou, Z. H. et al. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes. Liver Int 34, 58-68 (2014).
20. Pichlmair, A. et al. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol 12, 624-630 (2011).
21. Liu, X. Y. et al. IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1. J Immunol 187, 2559-2568 (2011).
22. Khvalevsky, E. et al. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. J Cell Biochem 100, 1301-1312 (2007).
23. Tsuge, M. et al. Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice. J Infect Dis 204, 224-228 (2011).
24. Krek, A. et al. Combinatorial microRNA target predictions. Nat Genet 37, 495-500 (2005).
25. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
26. Rehmsmeier, M. Fast and effective prediction of microRNA/target duplexes. Rna 10, 1507-1517 (2004).
27. John, B. et al. Human MicroRNA Targets. Plos Biology 2, e363 (2004).
28. Cameron, J. E. et al. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol 82, 1946-1958 (2008).
29. Wieland, S., Thimme, R., Purcell, R. H. & Chisari, F. V. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 101, 6669-6674 (2004).
30. Fletcher, S. P. et al. Transcriptomic analysis of the woodchuck model of chronic hepatitis B. Hepatology 56, 820-830 (2012).
31. Huang, C. F. et al. miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis. J Gastroenterol 50, 480-490 (2015).
32. Wang, J. Y. et al. Serum microRNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infection. J Viral Hepat 22, 128-136 (2015).
33. Lan, S. H. et al. Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224. Hepatology 59, 505-517 (2014).
34. Tomokuni, A. et al. miR-146a suppresses the sensitivity to interferon-alpha in hepatocellular carcinoma cells. Biochem Biophys Res Commun 414, 675-680 (2011).
35. Jiang, H. et al. Association of a single-nucleotide polymorphism within the miR-146a gene with susceptibility for acute-on-chronic hepatitis B liver failure. Immunogenetics 65, 257-263 (2013).
36. Sato, S. et al. The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus. Immunity 42, 123-132 (2015).
37. Paik, J. H. et al. MicroRNA-146a downregulates NFkappaB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res 17, 4761-4771 (2011).
38. Han, Q., Zhang, C., Zhang, J. & Tian, Z. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBxsiRNAs in a retinoic acid inducible gene I-dependent manner. Hepatology 54, 1179-1189 (2011).
39. Su, C. et al. Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells. Virol J 8, 354 (2011).
40. Labbaye, C. et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol 10, 788-801 (2008).
41. Chiu, C. M. et al. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci USA 104, 2571-2578 (2007).